Paraneoplastic cerebellar degeneration;Paraneoplastisk cerebellar degenerasjon: En kasuistikk

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 20, 1997, Pages 2947-2948

  Storstein, Anette ^a   Vedeler, Christian ^a   Krossnes, Bård ^a   Mørk, Sverre ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; CASE REPORT; CEREBELLUM; CEREBELLUM TUMOR; FEMALE; HUMAN; METASTASIS; OVARY TUMOR; PARANEOPLASTIC SYNDROME; PATHOLOGY; PURKINJE CELL;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; CEREBELLAR NEOPLASMS; CEREBELLUM; FEMALE; HUMANS; OVARIAN NEOPLASMS; PARANEOPLASTIC SYNDROMES; PURKINJE CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031591720     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Posner JB, Furneaux HM. Paraneoplastic syndromes. Immunological mechanisms in neurological and psychiatric disease. New York: Raven, 1990.
2. Posner JB. Neurological complications of cancer. New York: Davis, 1995.
3. Mygland Å. Neurologiske paraneoplastiske syndromer og antineuron-antistoffer. Tidsskr Nor Lægeforen 1996; 116: 361-5.
4. Dalmau J, Posner JB. Neurologic paraneoplastic antibodies: the case for a nomenclature based on antibody and antigen specificity. Neurology 1994; 44: 2241-6.
5. Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F et al. Selective expression of purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990; 332: 1844-51.
6. Moll JWB, Vecht CJ. Immune diagnosis of paraneoplastic neurological disease. Clin Neurol Neurosurg 1995; 97: 71-81.
7. Greenlee JE, Brashear HR, Rodnitzky RL, Corbett JJ, Digre KB. Fall in antineuronal antibody titers and improvement of neurologic deficit following tumor removal in paraneoplastic cerebellar degeneration. Neurology 1986; (suppl 37): 305-6.
8. Cocconi G, Ceci G, Juvarra G, Minopoli R, Cocchi T, Fiaccadori F et al. Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. Cancer 1985; 56: 2318-20.
9. Ben David Y, Warner E, Levtan M, Sutton DMS, Malkin MG, Dalmau J. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. Cancer 1996; 78: 2153-6.
10. Graus F, Vega F, Delattre JY, Bonaventura I, Rene R, Arbaiza D et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 1992; 42: 536-40.
11. Musarella MA, Chan HSL, DeBoer G, Callie BL. Ocular involvement in neuroblastoma: prognostic implications. Ophthalmology 1984; 91: 936